OBJECTIVE To review the literature on sialorrhea in children with cerebral palsy. SOURCE OF DATA Non-systematic review using the keywords "sialorrhea" and "child" carried out in the PubMed®, LILACS®, and SciELO® databases during July 2015. A total of 458 articles were obtained, of which 158 were analyzed as they were associated with sialorrhea in children; 70 had content related to sialorrhea...

OBJECTIVE The aim of this study was to examine the efficacy, safety and dosing practices of rimabotulinumtoxinB (BoNT-B) for the treatment of patients with sialorrhea based on a systematic review of clinical trials. METHODS A systematic literature review was performed to identify randomized controlled trials and other comparative clinical studies of BoNT-B for the treatment of sialorrhea publ...

INTRODUCTION Sialorrhea is problematic for many neurologically impaired patients. They suffer from excessive salivation because of inadequate oral motor control or swallowing dysfunction [1]. Persistent sialorrhea creates major hygienic and psychosocial problems. Maceration of skin around the mouth and neck may result in secondary bacterial infection. In addition, drooling is not a respectable ...

CONTEXT Dysphagia and sialorrhea in patients with Parkinson's disease are both automatically accepted as dependent on this neurological disease. OBJECTIVE The aim were to establish if these two complaints are a consequence or associated manifestations of Parkinson's disease. METHOD Two Parkinson's diseases groups from the same outpatients' population were studied. Patients in the first grou...

Background: Sialorrhea, the excessive flow of saliva from the mouth, causes distress in about half of patients with amyotrophic lateral sclerosis (ALS). Treatments of sialorrhea in ALS include systemic anticholinergic drugs, amitriptyline, botulinum toxin injection, and salivary gland radiotherapy, although each has limitations. Scopolamine transdermal patches have been used to prevent motion s...

OBJECTIVE To review the efficacy and safety of botulinum toxin A (BTX) in the treatment of sialorrhea. DATA SOURCES A PubMed search and reference list review was performed to find clinical trials on BTX in the treatment of sialorrhea. The search was limited to English-language trials involving human subjects. Articles from 1965 to October 2006 were searched, using key words botulinum, botulin...

INTRODUCTION: In some cases, saliva production (sialorrhea — hypersalivation) can be so significant that it needs to monitored and accounted for in the assessment maintenance of patient's water balance. OBJECTIVE: Description a clinical case sialorrhea, which had clinically manifestation balance 2-month-old child intensive care unit (ICU). MATERIALS AND METHODS: Baby, 2 month old, was treated I...

Upper and lower gastrointestinal dysautonomia symptoms (GIDS)--sialorrhea, dysphagia, and constipation are common in Parkinson's disease (PD) and often socially as well as physically disabling for patients. Available invasive quantitative measures for assessing these symptoms and their response to therapy are time-consuming, require specialized equipment, can cause patient discomfort and presen...

Sialorrhea or drooling represents quite a common problem in patients with amyotrophic lateral sclerosis (ALS). In this review, we describe the possible treatments for this issue. Current medical management is not always effective: anticholinergic drugs (atropine, glycopyrrolate, amitriptyline, hyoscyamine, and transdermal scopolamine) are often used, but there is very little evidence of their e...

Objectives: The objective of this study was to present our experience and evaluate results botulinum toxin A (BTX-A) injection applied major salivary glands in children with sialorrhea. Patients Methods: Seventeen pediatric patients (11 males, 6 females; mean age: 9.6±4.5 years; range, 4 17 years) who underwent BTX-A were included the study. severity complaints about sialorrhea evaluated using ...